Just briefly list out some of the "undervalue" stocks under my radar board. However only 2 fulfill my criteria, as i always stress that dividend yielding is my main criteria in picking stocks, try see below whether you can spot which one of it is my preference :-
1) EMIVEST
2) KHIND
3) GOPENG
4) KFIMA
5) TOMEI
Of the above, I have not listed one of my pick which recently i have just acquired some the other day. That counter has so far appreciated about 14% since i first pick, i am still in the accumulate stage if it ever drop to my target price.
Back to the above, only KFIMA is in my holding, i have yet to venture into any of the above. Of course, the above picked might not serve as save stocks to invest eventhough it is truely undervalue (under my own term) under current circumtances. Stock market changes everyday, no one can truely assured of anything but being "undervalue" certain risk has be diminished. For example it has steady earnings, good EPS, healthy BS and dividend & etc....
The above just serve as reference, so do not follow blindly as this may not fit into your way of pcking stocks. Till then happy trading.
9 comments:
Among all your listed undervalue stock, you must be pick khind. These stock also under my radar screen, surging from 90sen to as high as 1.10. it has double dividend payout from 5sen to current 10sen, but still sustainable since its EPS was 20sen.
Today, both portfolio have reach ultramax margin line; bought TH plant at 1.50; Cresbld at 73sen and Tomei at 54sen.
Update portfolio + ultramargin line
1. Keladi 65.6% (cost: 15.7sen)
2. Pharma 63.7% (cost: RM 4.30)
3. PIE 60.8% (cost: RM 4.00)
4. Tomei 30% (cost 55 sen)
4. Yilai 8.7% (cost 75sen)
5. LCTH 8.1% (cost 33.5sen)
6. UPA 8.2% (cost 1.40)
7. Cresbld 4.9% (cost 73sen)
Second portfolio + margin line
1. TH Plantation 205% (cost: 1.52)
2. Keladi 28.2% (cost: 16.2sen)
3. Chuan 16.2% (cost 60.5sen)
today, sold keladi at 16sen, realize marginal paper profit; swap these margin line to buy CCM Duopharma; bought at 2.38
Update portfolio + ultramargin line
1. Pharma 63.7% (cost: RM 4.30)
2. PIE 60.8% (cost: RM 4.00)
3. Keladi 53% (cost: 15.7sen)
4. Tomei 30% (cost 55 sen)
5. CCM Duopharma 12% (cost 2.38)
6. Yilai 8.7% (cost 75sen)
7. LCTH 8.1% (cost 33.5sen)
8. UPA 8.2% (cost 1.40)
9. Cresbld 4.9% (cost 73sen)
Second portfolio + margin line
1. TH Plantation 205% (cost: 1.52)
2. Keladi 28.2% (cost: 16.2sen)
3. Chuan 16.2% (cost 60.5sen
today, sold some keladi at 16sen, realize marginal paper profit; swap these margin line to buy LCTH at 34.5-35sen
Update portfolio + ultramargin line
1. Pharma 63.7% (cost: RM 4.30)
2. PIE 60.8% (cost: RM 4.00)
3. Keladi 44.5% (cost: 15.7sen)
4. Tomei 30% (cost 55 sen)
5. LCTH 16.8% (cost 33.5sen)
6. CCM Duopharma 12% (cost 2.38)
7. Yilai 8.7% (cost 75sen)
8. UPA 8.2% (cost 1.40)
9. Cresbld 4.9% (cost 73sen)
Second portfolio + margin line
1. TH Plantation 205% (cost: 1.52)
2. Keladi 28.2% (cost: 16.2sen)
3. Chuan 16.2% (cost 60.5sen
LCTH just declare final div of 8.9%.... :)
Yeah! LCTH declare final dividend 8.9% or 1.78sen; yield 5.1%. My average cost for LCTH should be about 34.3sen.
These stock have dividend policy to payout at least 50% net profit (about 75%) as dividend, and used to pay dividend almost every quarter.
Portfolio still waiting PIE to proposed its dividend.
hng,
well done, lcth deliver now.
today, sold off all LCTH at 35.5sen; realize few k profit :), swap these margin line to buy Bonia at 1.00-1.01; some Yilai at 78sen
Update portfolio + ultramargin line
1. Pharma 63.7% (cost: RM 4.30)
2. PIE 60.8% (cost: RM 4.00)
3. Keladi 44.5% (cost: 15.7sen)
4. Tomei 30% (cost 55 sen)
5. Bonia 12.3% (cost 33.5sen)
6. CCM Duopharma 12% (cost 2.38)
7. Yilai 11.2% (cost 75sen)
8. UPA 8.2% (cost 1.40)
9. Cresbld 4.9% (cost 73sen)
Second portfolio + margin line
1. TH Plantation 205% (cost: 1.52)
2. Keladi 28.2% (cost: 16.2sen)
3. Chuan 16.2% (cost 60.5sen
horse
Your stock holding Pbbank; Lonbisc; Khind; GAB; Kfima; Panamy; TNB etc all soar year high. I think your year to date already outperform KLCI, on total paper profit at least 20%, Well done for buy and hold strategy :)
Update portfolio + ultramargin line
1. Pharma 63.7% (cost: RM 4.30)
2. PIE 60.8% (cost: RM 4.00)
3. Keladi 44.5% (cost: 15.7sen)
4. Tomei 30% (cost 55 sen)
5. Bonia 12.3% (cost 1.05)
6. CCM Duopharma 12% (cost 2.38)
7. Yilai 11.2% (cost 76sen)
8. UPA 8.2% (cost 1.40)
9. Cresbld 4.9% (cost 73sen)
Second portfolio + margin line
1. TH Plantation 205% (cost: 1.52)
2. Keladi 28.2% (cost: 16.2sen)
3. Chuan 16.2% (cost 60.5sen
Post a Comment